Omada Health reported second quarter 2026 financial results with revenue of $88 million, a 43% year-over-year increase, and raised full-year guidance to $334–$340 million. The company achieved its first profitable quarter with net income of $5 million and adjusted EBITDA of $11 million. Concurrently, the Board announced that CEO Sean Duffy will transition to Executive Chairman on January 1, 2027, succeeded by President Wei-Li Shao as CEO. Jeryl Hilleman was appointed Lead Independent Director effective the same date. Omada Health operates in the digital health industry, providing virtual chronic care management programs for conditions such as diabetes and hypertension.